SYGNATURE DISCOVERY
Dead / Abandoned — International registration dead — extension of protection cancelled (as of 14 Nov 2025)
What this means for you
This application is over — abandoned 14 Nov 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79411026
- Mark type
- Design + words
- Filed
- 27 Sept 2024
- Abandoned
- 14 Nov 2025
Goods and services
- Class 001 — Chemicals: Proteins for use in industry; proteins for use in manufacture; proteins for use in science; proteins for use in the manufacture of pharmaceutical products; raw proteins; raw proteins for use in industry; raw proteins for use in manufacture; raw proteins for use in science; raw proteins for use in the manufacture of pharmaceutical products.
- Class 040 — Treatment of materials: Processing of organic chemical liquids; recycling of organic solvents; purification of proteins; purification of proteins by chemical methods.
- Class 042 — Scientific and technological services: Scientific research and development services; drug discovery services; development of pharmaceutical preparations and medicines; drug screening for scientific purposes; pharmaceutical drug development services; research and development of vaccines and medicines; research and development of drugs; research relating to medicines; services for assessing the efficacy of drugs; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to pharmaceutical research and developments; development of pharmaceutical preparations and medicines; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; proving medical and scientific research information in the field of pharmaceuticals and drug development; research and development in the pharmaceutical and drug development fields; testing of pharmaceutical drugs; assay development services; biological research; biological analysis; biological development services; biological laboratory services; biological research, clinical research and medical research; consultancy relating to pharmacology; medical and pharmacological research services; scientific research for medical purposes; research in the field of synthetic biology; research and development in the field of microorganisms and cells; chemical research and analysis services; chemical engineering; chemistry services; medicinal, synthetic, analytical and high throughput chemistry services; clinical research; organic chemistry research and analysis services; consultancy in the field of organic chemistry; laboratory research and analysis services in the field of organic chemistry; research and development services in the field of organic chemistry; development, testing and analysis of chemicals; development, testing and analysis of chemical production methods; protein and peptide mapping for scientific purposes; scientific analysis services; protein analysis services for scientific purposes; protein sequencing research; protein crystallisation screening for scientific purposes; quality control; testing of materials; testing of products; technological research; industrial analysis and research services; scientific services relating to cell line generation; scientific screening services; compound profiling and selectivity services; X-ray imaging, other than for medical purposes; blood analysis services; blood analysis services for scientific research purposes; information, advisory and consultancy services relating to the aforesaid services.
Owner
Prosecution history
- 30 Nov 2025 — DEATH OF INTERNATIONAL REGISTRATION
- 06 Nov 2025 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 06 Nov 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 09 May 2025 — REFUSAL PROCESSED BY IB
- 24 Apr 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 24 Apr 2025 — REFUSAL PROCESSED BY MPU
- 14 Mar 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 13 Mar 2025 — NON-FINAL ACTION WRITTEN
- 12 Mar 2025 — ASSIGNED TO EXAMINER
- 29 Nov 2024 — APPLICATION FILING RECEIPT MAILED
- 29 Nov 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Nov 2024 — SN ASSIGNED FOR SECT 66A APPL FROM IB